|
|
|
| Webinar: Breaking Barriers with PCR: Innovative Solutions for Clinical Trial Success | Designing PCR-based testing strategies for clinical trials requires not only technical precision but also thoughtful decisions around assay selection, platform capabilities, and clinical relevance. Join experts from Precision for Medicine, as well as guest speakers from Avidity Biosciences and Indaptus Therapeutics, as they explore how PCR-based molecular monitoring drives smarter, faster, and more efficient personalized clinical trials. Register Now |
|
|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Ray Dogum, Chief Editor, Drug Discovery Online | New Approach Methods (NAMs) are rapidly being accepted as replacements for preclinical animal tests long considered to be the gold standard. NAMs include systems of organoids, organs-on-chips, AI-based prediction models, and non-mammalian species. | |
|
|
| What Is Transfection? | Article | Mirus Bio | Learn about the process of transfection and why it is crucial for studying gene function and has applications in various fields, including drug development and gene therapy. |
|
|
| mTOR Pathway | Article | Danaher Life Sciences | Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues. |
|
|
|
|
|
| Accelerate Antibody Development And Production | e-book | MaxCyte, Inc. | MaxCyte's electroporation platform accelerates therapeutic antibody development with scalable, high-efficiency transfection, enabling rapid transient protein expression, and IND-enabling studies in weeks. |
|
|
|
|
| Webinar: Advances in Pediatric Transplant: T-cell Depleted Haploidentical Experience | Join Miltenyi Biotec for an insightful live webinar on transforming pediatric transplant care with T cell–depleted haploidentical HSCT. Learn how this cutting-edge approach expands donor access while minimizing GVHD risk. Hear firsthand clinical experiences, explore immune recovery data, and discover how virus-specific T cells may shape the future of transplantation. Don't miss this opportunity to deepen your expertise—register now! Click here to learn more. |
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Cell & Gene: |
|
|
|
